Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte to Present at the Jefferies Virtual Healthcare Conference
May 27, 2021 16:05 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
May 11, 2021 16:10 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease
May 10, 2021 08:30 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte to Present at BofA Securities 2021 Health Care Conference
May 06, 2021 16:05 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
April 05, 2021 16:30 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
March 29, 2021 16:10 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
March 22, 2021 16:05 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections
January 06, 2021 08:15 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
December 22, 2020 08:00 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte_Logo_CMYK_M01.jpg
Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
November 24, 2020 16:05 ET | Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...